Drawing for VIDELITY

USPTO serial 79318927

VIDELITY

Reviewed by CopyMark Law Group

Reg. 6641712Status 404
Filing date
Status date
Registration date
Feb 15, 2022
Examiner
DOMBROW, COLLEEN M
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIDELITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile software applications for disease management and tracking patient compliance with medical treatmentsSECTION 70 - CANCELLED—
010Medical apparatus and instruments for diagnosis and treatment of respiratory conditions, diabetes, cardiovascular and metabolic disorders, diseases of the nervous system, inflammatory disorders, infectious diseases and for use in dermatologySECTION 70 - CANCELLED—
044Medical services, namely, providing healthcare informationSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 12, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 4, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jun 3, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 3, 2022FIMPFINAL DISPOSITION PROCESSED—
Mar 17, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Feb 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2021GPNXNOTIFICATION PROCESSED BY IB—
Dec 8, 2021CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Dec 1, 2021APETASSIGNED TO PETITION STAFF—
Nov 30, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 30, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 18, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 17, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 22, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 16, 2021DOCKASSIGNED TO EXAMINER—
Sep 15, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 15, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 15, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 15, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 15, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 7, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 2, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 1, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 26, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance